In addition to EZH2, Ma et al. [100] showed that the TMPRSS2:ERG activates SRY-box 9 (SOX9), which stimulates WNT signaling and tumor progression in a subset of prostate cancer. Here, SOX9 is linked to prostate carcinoma.